PLIVA 327 (Hydralazine Hydrochloride 25 mg)
Pill with imprint PLIVA 327 is Orange, Round and has been identified as Hydralazine Hydrochloride 25 mg. It is supplied by Teva Pharmaceuticals.
Hydralazine is used in the treatment of high blood pressure; hypertensive emergency; heart failure and belongs to the drug class vasodilators. Risk cannot be ruled out during pregnancy. Hydralazine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PLIVA 327
Hydralazine Hydrochloride
- Imprint
- PLIVA 327
- Strength
- 25 mg
- Color
- Orange
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Vasodilators
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals
- National Drug Code (NDC)
- 50111-0327
- Inactive Ingredients
-
lactose anhydrous, FD&C Yellow No. 6, microcrystalline cellulose, sodium starch glycolate type A potato, stearic acid
Note: Inactive ingredients may vary.
More about hydralazine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 66 Reviews
- Drug class: vasodilators
- FDA Alerts (1)
Consumer resources
- Hydralazine
- Hydralazine Injection (Advanced Reading)
- Hydralazine Oral, Injection, Intravenous (Advanced Reading)
- Hydralazine Tablets
- Hydralazine Injection
Other brands: Apresoline
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
